IMM 5.36% 29.5¢ immutep limited

Ann: Immutep collaborates with MSD for phase 2b head & neck trial, page-12

  1. 245 Posts.
    lightbulb Created with Sketch. 139
    Hey Craigos,

    Sometimes a piece of news comes along that when analyzed indicates you should expand you holdings.

    Like Oldbull26 posted "Advancing to this later stage Phase IIb trial will allow us to explore the combination
    therapy in the commercially relevant 1st line therapy
    setting which has a high unmet medical need,”

    What does this mean?
    It means if you have cancer that can take out you vocal cords you now have a chance to live
    and still be able to talk. WITHOUT an electronic device!!

    We don't know if this is going to work but if it does this will be a quantum leap in cancer care.
    And in a small way we shareholders are helping in the fight against disease.
    Massive breakout maybe but slow steady progress is what we have seen and hopefully will continue to see.
    If it hasn't gone up too much I will expand my holdings tomorrow
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
0.015(5.36%)
Mkt cap ! $428.5M
Open High Low Value Volume
28.5¢ 30.5¢ 28.0¢ $833.4K 2.824M

Buyers (Bids)

No. Vol. Price($)
8 388130 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 39940 3
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.